T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
TriMas Corp
TRS
$1.41B
| $60.9M | 0.01% |
2,442,205
+9,915
| +0.4% | +$234K |
|
|
NILE
777
DELISTED
Blue Nile, Inc.
NILE
| $60.9M | 0.01% |
1,690,759
+5,200
| +0.3% | +$172K |
|
|
SWC
778
DELISTED
Stillwater Mining Co
SWC
| $60.9M | 0.01% |
4,129,391
+472,330
| +13% | +$6.48M |
|
779
Ambev
ABEV
$43.5B
| $60.6M | 0.01% |
9,750,000
+733,100
| +8% | +$4.63M |
|
780
Fabrinet
FN
$20.5B
| $60.3M | 0.01% |
3,399,040
+44,800
| +1% | +$746K |
|
|
XXIA
781
DELISTED
Ixia
XXIA
| $60.3M | 0.01% |
5,355,880
+721,030
| +16% | +$7.08M |
|
|
IMS
782
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $59.8M | 0.01% |
2,333,090
+69,100
| +3% | +$1.74M |
|
783
Royal Gold
RGLD
$19.7B
| $59.7M | 0.01% |
951,597
+58,350
| +7% | +$3.83M |
|
784
Forum Energy Technologies
FET
$932M
| $59.5M | 0.01% |
143,610
+1,665
| +1% | +$822K |
|
|
PPL
785
PPL Corp
PPL
$26.7B
| $59.5M | 0.01% |
1,758,291
-34,035
| -2% | -$1.11M |
|
|
ASEI
786
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $59.3M | 0.01% |
1,142,783
+83,220
| +8% | +$4.16M |
|
787
Commerce Bancshares
CBSH
$8.56B
| $59.3M | 0.01% |
2,331,690
+78,953
| +4% | +$1.97M |
|
788
Cavco Industries
CVCO
$4.6B
| $59.2M | 0.01% |
746,277
-6,633
| -0.9% | -$487K |
|
|
ACC
789
DELISTED
American Campus Communities, Inc.
ACC
| $59.1M | 0.01% |
1,428,026
+42,830
| +3% | +$1.69M |
|
790
Black Hills Corp
BKH
$5.58B
| $58.9M | 0.01% |
1,110,055
-8,370
| -0.7% | -$441K |
|
791
Albany International
AIN
$1.81B
| $58.8M | 0.01% |
1,548,043
+11,800
| +0.8% | +$426K |
|
|
CIR
792
DELISTED
CIRCOR International, Inc
CIR
| $58.5M | 0.01% |
970,320
-6,340
| -0.6% | -$417K |
|
|
IRBT
793
DELISTED
iRobot
IRBT
| $57.9M | 0.01% |
1,669,000
-512,730
| -24% | -$17.6M |
|
794
CF Industries
CF
$18.2B
| $57.9M | 0.01% |
1,061,490
+154,075
| +17% | +$8.12M |
|
795
Ultragenyx Pharmaceutical
RARE
$2.65B
| $57.8M | 0.01% |
1,316,140
-750
| -0.1% | -$34.4K |
|
796
Moody's
MCO
$82.8B
| $57.4M | 0.01% |
598,731
+735
| +0.1% | +$71.3K |
|
|
GAP
797
The Gap Inc
GAP
$7.29B
| $56.7M | 0.01% |
1,345,725
-1,001,657
| -43% | -$39.3M |
|
|
UTIW
798
DELISTED
UTI WORLDWIDE INC
UTIW
| $56.6M | 0.01% |
4,692,070
+1,420,440
| +43% | +$15.9M |
|
|
CHSP
799
DELISTED
Chesapeake Lodging Trust
CHSP
| $56.2M | 0.01% |
1,510,600
-92,090
| -6% | -$3.06M |
|
|
AVX
800
DELISTED
AVX Corporation
AVX
| $56.1M | 0.01% |
4,010,002
+430,589
| +12% | +$5.94M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.